Mediahub Wins Account For Radiant Health, Extends Its Trans-Tasman Offering
Following a competitive pitch, multi-national healthcare and pharmaceutical company iNova has appointed Mediahub as its ...
Pharmaceutical Technology10h
Incyte stock hit 11% despite paediatric dermatology trials hitting target
The two simultaneous Incyte trials in HS saw more than 40% of patients on povorcitinib achieving a clinical response.
MT Newswires on MSN11h
European Equities Traded in the US as American Depositary Receipts Track Higher in Monday Trading
European equities traded in the US as American depositary receipts kicked off the week higher late Monday morning, rising 1.12% to 1,433.84 on the S&P Europe Select ADR Index. From continental Europe, ...
PharmiWeb11h
2025 PM Society Awards – Winners Announced
The 39th PM Society Awards, supported by headline sponsor Avalere Health, were held on 14th March, 2025, at the JW Marriott Grosvenor House London. The industry came together for this prestigious ...
The evolution of pharma marketing: How to reach consumers in the age of digital health
Pharma brands that fail to evolve risk losing relevance in a world where patients demand more control, transparency, and ...
Hair loss drug finasteride can cause debilitating side-effects, men say
The 35-year-old living in Mississauga, Ont., had been concerned about losing his hair. The medication, a popular drug called finasteride, promised to curb the issue. His doctor warned him side-effects ...
Pfizer Has a New Playbook for Reviving Sales—and It’s Starting to Pay Off
The drugmaker has revamped how it packages, promotes and sells certain medicines in an effort to overcome a postpandemic ...